Oct. 22, 2024 — Realizing a Phase I human clinical trial commencing to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord ...
Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...
This review discusses use of RFA for back pain including facetogenic pain, including cervical and lumbar pain ... is discharged home with physical therapy instructions and an abdominal binder.
The use of facet median nerve branch radiofrequency ablation (RFA) for cervical, thoracic and lumbar vertebrae is common but more randomized, double-blinded control studies are needed in this area.